Skip to main content
. 2010 Oct 4;119(1):78–83. doi: 10.1289/ehp.1002258

Table 3.

Comparison of data for influenza B HA RNA quantity (as ratio to β-actin) during study days 1–4 among controls, SHS-exposed subjects, and active smokers [median (interquartile range)].

Parameter Controls (n = 15) SHS (n = 16) Smokers (n = 11)
Maxday 1–4a 3.2 (0.5–33.2) 20.9 (4.5–145.1) 96.8* (9.6–265.8)
AUCday 1–4b 5.1 (0.7–30.5) 21.3 (4.2–138.7) 226.8* (20.2–880.0)
a

Maximum HA RNA quantity, day 1–4 after LAIV inoculation.

b

AUC HA RNA quantity, day 1–4 after LAIV inoculation.

*

p < 0.05 vs. control, Kruskal–Wallis test with Dunn’s posttest.

HHS Vulnerability Disclosure